Related Experiment Videos
[Effect of hormone replacement therapy during the climacteric on cerebrovascular diseases]
1Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Universität zu Köln.
Insights
Hormone replacement therapy (HRT) reduces stroke risk and improves cerebrovascular health. Studies show HRT decreases atherosclerosis and plaque formation, offering benefits for stroke prevention.
Area of Science:
- Neurology
- Endocrinology
- Cardiovascular Science
Context:
- Epidemiological and animal studies indicate hormone replacement therapy (HRT) may decrease stroke risk.
- Estrogen's positive effects on the cerebrovascular system have been observed via sonographical blood flow measurements.
- Gestagens do not appear to modify estrogen's positive impact on cerebrovascular function.
Purpose:
- To investigate the effects of hormone replacement therapy (HRT) on cerebrovascular health and stroke risk.
- To evaluate the long-term influence of HRT on markers of atherosclerosis, such as intima-media thickness.
- To assess the efficacy of HRT in preventing and managing cerebrovascular diseases, including stroke.
Summary:
- HRT demonstrated a reduction in intima-media thickness, a marker of atherosclerosis, in morphometric investigations.
- Sonographical measurements indicated that HRT positively impacts the cerebrovascular system.
- Patients receiving HRT showed significantly fewer atherosclerotic plaques compared to a control group, with evidence of plaque regression in some cases.
Impact:
- HRT shows clear benefits for the prevention of cerebrovascular diseases, even in heterogeneous stroke patient groups.
- HRT is not contraindicated for patients with cerebrovascular diseases and is often recommended.
- Further prospective studies are warranted to confirm the therapeutic effects of HRT for cerebrovascular disease.
Abstract:
In epidemiological and animal studies it could be shown that a hormone replacement therapy decreased the risk of stroke. Sonographical blood flow measurement shows a positive effects to the cerebrovascular system caused by estrogen which was not modified by gestagens. In morphometric investigations by sonographical measurements of intima-media-thickness, it could be demonstrated that a positive influence by hormone replacement therapy can be achieved for a longer time. The intima-media-thickness, as a sign of a complex atherosclerosis, is decreased. The number of atherosclerotic plaques is significantly lower in patients receiving hormone replacement therapy (HRT) in comparison to a control group. A regression of the plaques by estrogen replacement therapy could be shown in one study. Although the group of patients suffering from stroke is heterogeneous, the benefit of HRT for prevention of cerebrovascular diseases could clearly be demonstrated. HRT is not contraindicated in patients suffering from cerebrovascular diseases. In most of cases, HRT is recommended in these patients. The therapeutic effect of HRT for cerebrovascular disease should be proved in further prospective studies.